Pure Global

Abbott "Marisi" hepatitis B surface antigen third-generation test reagent - Taiwan Registration 57b3f5801acb92336949f85e4b9f3033

Access comprehensive regulatory information for Abbott "Marisi" hepatitis B surface antigen third-generation test reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 57b3f5801acb92336949f85e4b9f3033 and manufactured by DIASORIN S.P.A. UK BRANCH. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
57b3f5801acb92336949f85e4b9f3033
Registration Details
Taiwan FDA Registration: 57b3f5801acb92336949f85e4b9f3033
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Abbott "Marisi" hepatitis B surface antigen third-generation test reagent
TW: ไบžๅŸนโ€ๅฆ™่Šฎ็ตฒโ€Bๅž‹่‚็‚Ž่กจ้ขๆŠ—ๅŽŸ็ฌฌไธ‰ไปฃๆชข้ฉ—่ฉฆๅŠ‘
Risk Class 3

Registration Details

57b3f5801acb92336949f85e4b9f3033

DHA00601174001

Company Information

Product Details

Enzyme immunoassay for legal testing of hepatitis B virus surface antigen in human serum or plasma.

B Hematology, pathology, and genetics

B.4020 Analysis of specific tests

import

Dates and Status

Aug 08, 2005

Aug 06, 2027